Valentina Poretto

Valentina Poretto

Auto-generated profile, based on publicly available information

Valentina Poretto

Neurology Unit (V.P., S. Tonello), Department of Neuro-Cardiovascular Medicine, Ca’ Foncello Hospital, Treviso, Italy

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2012 in Brain
Verified
Journal Article
Closed access
PDF file
Massimiliano CalabreseMassimiliano Calabrese
Massimiliano Calabrese
VPValentina Poretto
Valentina Poretto
AFAlice Favaretto
Alice Favaretto
SASara Alessio
Sara Alessio
VBValentina Bernardi
Valentina Bernardi
PGPaolo Gallo
Paolo Gallo
Cortical inflammatory lesions have been correlated with disability and cortical atrophy in multiple sclerosis. The extent to which cortical lesion load is associated with longer-term physical and cognitive disability in different multiple sclerosis phenotypes has not yet been investigated. Thus, a 5-year prospective longitudinal study was carried on in a large group of patients with multiple sclerosis. Three hundred and twelve consecutive patients suffering from multiple sclerosis (157 relapsing remitting, 35 paediatric, 45 benign, 44 primary progressive and 31 secondary progressive) were enrolled in a 5-year prospective clinical and neuroimaging study. Several magnetic resonance parameters (including cortical lesion number and volume, contrast-enhancing cortical lesions and grey matter atrophy) were analysed to find associations with clinical and cognitive outcomes. Patients with high cortical lesion load had higher Expanded Disability Status Scale increase (median = 1.5; range = 0–3) during the study than both patients with low cortical lesion load (median = 1.0; range = 1–3, P < 0.001) and without cortical lesions (median = 0.5; range = −1 to 2, P < 0.001). Compared with clinically stable patients, 101 (32.4%) patients showing clinical progression at 5 years had the highest rate of cortical lesion accumulation (P < 0.001). Stepwise regression analysis revealed significant and independent contributions from age (β = 0.55), cortical lesion volume (β = 0.58), T2 white matter lesion volume (β = 0.34) and grey matter fraction (β = 0.42) as predictors (final model with r2 = 0.657, P < 0.001) of Expanded Disability Status Scale change. Disease duration (β = 0.52, P < 0.001), cortical lesion volume (β = 0.67, P < 0.001), grey matter fraction (β = 0.56, P < 0.001) and T2 white matter lesion volume (β = 0.31, P = 0.040) at baseline were found to be independent predictors of cognitive status at the end of the study. While confirming the relevance of cortical pathology in all multiple sclerosis phenotypes, but benign, our study suggests that grey matter and white matter changes in multiple sclerosis occur, at least, partly independently, and that grey matter, more than white matter, damage is associated with physical and cognitive disability progression. Thus, the combination of grey and white matter parameters gives a more comprehensive view of multiple sclerosis pathology and allows a better understanding of the progressive phase of the disease, which, however, seems more related to cortical damage than to subcortical white matter changes.

16 October 2012 in Neurology
Verified
Journal Article
Closed access
PDF file
Massimiliano CalabreseMassimiliano Calabrese
Massimiliano Calabrese
MOMi Sun Oh
Mi Sun Oh
AFAlice Favaretto
Alice Favaretto
FRFrancesca Rinaldi
Francesca Rinaldi
VPValentina Poretto
Valentina Poretto
PGPaolo Gallo
Paolo Gallo
Background: Neuromyelitis optica (NMO) is a severe inflammatory demyelinating disease of the CNS in which a pathogenic role of anti-aquaporin-4 (AQP4) antibodies has been suggested. Although AQP4 is expressed in human cortex, recent histologic studies have failed to find any evidence of cortical demyelination in NMO. Objective: To evaluate, in vivo, the occurrence of focal and diffuse cortical pathology in NMO. Methods: We studied 30 patients with NMO, 30 patients with relapsing-remitting multiple sclerosis (RRMS), and 30 normal controls (NC). RRMS and NC were age- and gender-matched to NMO. The presence of cortical lesions (CLs) was evaluated on double inversion recovery sequence and cortical thickness (CTh) by the application of Freesurfer on 3 volumetric fast field echo T1-weighted images. Results: No CL was observed in NC or in NMO, while 83 CLs were identified in 20/30 (66.7%) patients with RRMS. Although NMO did not differ from NC in the global CTh, a mild thinning was observed in some cortical areas (postcentral [p = 0.018], precentral [p = 0.009], and calcarine [p = 0.015] gyri) and in the thalamus (p = 0.036). Global and regional cortical thickness was significantly decreased in RRMS compared to both NMO and NC. Discussion: Our in vivo data further suggest that the immune-mediated pathologic process occurring in NMO spares most of the cortex. NMO differs from multiple sclerosis, where CLs and atrophy are frequently found, even in early disease phases. Thus, MRI analysis of the cortex may be a potential diagnostic tool, especially in ambiguous cases.

12 March 2013 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
Massimiliano CalabreseMassimiliano Calabrese
Massimiliano Calabrese
CRChiara Romualdi
Chiara Romualdi
VPValentina Poretto
Valentina Poretto
AFAlice Favaretto
Alice Favaretto
AMAldo Morra
Aldo Morra
PGPaolo Gallo
Paolo Gallo

15 October 2012 in Multiple Sclerosis Journal
Verified
Journal Article
Closed access
Massimiliano CalabreseMassimiliano Calabrese
Massimiliano Calabrese
AFAlice Favaretto
Alice Favaretto
VPValentina Poretto
Valentina Poretto
CRChiara Romualdi
Chiara Romualdi
FRFrancesca Rinaldi
Francesca Rinaldi
PGPaolo Gallo
Paolo Gallo
Although a more favorable course of multiple sclerosis is associated with a low degree of cortical pathology, only longitudinal studies could definitely confirm this association. We followed 95 early relapsing–remitting MS (RRMS; median Expanded Disability Status Scale (EDSS) = 1.5, mean disease duration = 3.1 ± 1.3 years) and 45 benign MS patients (EDSS ≤ 3.0, disease duration ≥ 15 years, normal cognition) for 6 years, with EDSS evaluations every 6 months and brain magnetic resonance imaging (MRI) at baseline and then yearly. At baseline, we detected 406 cortical lesions (CLs) in 67/95 (70.5%) early RRMS and in 24/45 (53.3%) benign MS patients (p = 0.046). After 6 years, the appearance of new CLs was observed in 80/95 (84.2%; 518 CLs) of our early RRMS and in 25/45 (55.5%; 63 CLs; p < 0.001) benign MS patients. At baseline, after corrections for age and disease duration, we observed a cortical thinning of several frontal and temporal regions in our RRMS study patients, compared to the benign MS patients (p ranging between 0.001–0.05). After 6 years, the cortical thinning had increased significantly in several cortices of RRMS patients, but only in the occipital-temporal (p = 0.036) and superior parietal gyrus (p = 0.035) of those with benign MS. Stepwise regression analysis revealed the CL volume (p = 0.006) and the cortical thickness of the temporal middle (p < 0.001), insular long (p < 0.001), superior frontal (p < 0.001) and middle frontal gyri (p < 0.001) as the most sensitive independent predictors of a favorable disease course. Our data confirmed that a significantly milder cortical pathology characterizes the most favorable clinical course of MS. Measures of focal and diffuse grey matter should be combined to increase the accuracy in the identification of a benign MS course.

31 December 2015 in BMJ Open Gastroenterology
Verified
Journal Article
Open access
PDF file
SRSilvia Rosi
Silvia Rosi
VPValentina Poretto
Valentina Poretto
MCMarta Cavallin
Marta Cavallin
PAPaolo Angeli
Paolo Angeli
PAPiero Amodio
Piero Amodio
SMSara Montagnese
Sara Montagnese
Details of two patients with alcohol-related and mixed aetiology cirrhosis who developed acute-on-chronic liver failure/hepatic decompensation with no obvious precipitants are reported. Cytomegalovirus (CMV) infection or reactivation was diagnosed in both, and required treatment with ganciclovir in one. Both returned to baseline hepatic function and remain well. Physicians should be alert to the possibility that CMV might cause or contribute to hepatic decompensation in patients with cirrhosis, even if they are not severely immunocompromised, and especially if they are alcohol misusers.

1 November 2011 in Expert Review of Neurotherapeutics
Verified
Journal Article
Closed access
Massimiliano CalabreseMassimiliano Calabrese
Massimiliano Calabrese
FRFrancesca Rinaldi
Francesca Rinaldi
VPValentina Poretto
Valentina Poretto
PGPaolo Gallo
Paolo Gallo
The way we think of multiple sclerosis (MS) pathology has significantly changed over the last 10 years. Several studies clearly indicate that MS has to be considered a gray and white matter disease, where gray matter pathology probably plays a relevant role in determining physical and cognitive disability. The reviewed article presents new cross-sectional data on gray matter and white matter volumes across different MS phenotypes in a very large group of MS patients. In their study, the authors confirm an early and substantial deterioration of gray matter in MS and the evidence of a primary role of gray matter atrophy in the progression of clinical and cognitive disability. Another preliminary exciting step has therefore been taken toward the comprehension of the MS puzzle.